Astera Labs (NASDAQ:ALAB) Given New $225.00 Price Target at TD Cowen

Posted by Brian Himes on Nov 4th, 2026

Astera Labs (NASDAQ:ALAB – Get Free Report) had its price objective lowered by research analysts at TD Cowen from $300.00 to $225.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen‘s price objective points to a potential upside of 2.10% from the stock’s current price.

A number of other research firms have also commented on ALAB. Needham & Company LLC cut their price objective on Astera Labs from $425.00 to $300.00 and set a “buy” rating on the stock in a research note on Wednesday. Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Morgan Stanley lifted their price objective on shares of Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a research note on Wednesday. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research note on Wednesday. Finally, Barclays upped their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Twelve research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $318.00.

Get Our Latest Analysis on ALAB

Astera Labs Price Performance

Shares of Astera Labs stock traded down $13.26 during trading on Wednesday, hitting $220.36. The company’s stock had a trading volume of 5,600,957 shares, compared to its average volume of 5,099,883. The stock has a market cap of $38.23 billion, a price-to-earnings ratio of 109.42 and a beta of 3.85. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a 50-day moving average price of $306.13 and a two-hundred day moving average price of $255.53.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. During the same period last year, the company earned $0.49 EPS. Astera Labs’s revenue for the quarter was up 153.6% compared to the same quarter last year. On average, equities analysts predict that Astera Labs will post 2.71 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares in the company, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock valued at $127,306,034 in the last three months. Insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in ALAB. BlackRock Inc. bought a new position in shares of Astera Labs in the second quarter valued at approximately $6,609,581,000. Bank of America Corp DE purchased a new position in Astera Labs in the second quarter worth $1,061,791,000. Atreides Management LP boosted its position in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Amundi grew its stake in Astera Labs by 77.9% in the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after purchasing an additional 823,477 shares during the period. Finally, Deutsche Bank AG bought a new position in Astera Labs in the 2nd quarter valued at $325,602,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Q3 revenue reached a record $584.9 million, up 154% year over year, and adjusted earnings of $1.32 per share topped estimates of $1.19. Scorpio fabric switches were the largest product family, and management forecast Q4 revenue of $730 million to $750 million. Astera Labs Q3 results
Positive Sentiment: Northland upgraded ALAB to outperform, while Morgan Stanley raised its price target to $389 and maintained an overweight rating—signs that some analysts see substantial upside. Northland recommendation
Positive Sentiment: Astera is expanding beyond Scorpio into optical connectivity, memory and rack-scale AI systems, which could provide additional growth drivers over time. Q3 call highlights
Neutral Sentiment: Analyst views were mixed: RBC cut its target to $400 but kept an outperform rating, while Seeking Alpha upgraded its rating to Hold, citing strong execution but a still-expensive valuation. Seeking Alpha analysis
Negative Sentiment: Susquehanna lowered its target to $258 and retained a neutral rating. Concerns include ALAB’s valuation, reliance on a few customers and competition from Marvell’s push into optical connectivity—factors that may help explain why the shares fell despite the earnings beat. Barron’s coverage

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.